Cite
HARVARD Citation
Santangelo, A. et al. (2021). A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib. Neuro-oncology. 23 (2), pp. 264-276. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Santangelo, A. et al. (2021). A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib. Neuro-oncology. 23 (2), pp. 264-276. [Online].